KAAACI Allergic Rhinitis Guidelines: Part 2. Update in Non-pharmacological Management

Park, Do Yang; Lee, Yong Ju; Kim, Chang Woo; Kim, Soo Whan; Yang, Hyeon Jong; Kim, Do Hyun; Jun, Young Joon; Park, Sang Chul; Kim, Bong‐Seong; Yang, Song-I; Lee, Il Hwan; Kim, Minji; Ryu, Gwanghui; Kang, Sung Yoon; Kim, Mi-Ae; Lee, Sang Min; Kim, Hyun Jung; Choi, Gil Soon; Chung, Soo Jie; Lee, Hyun Jong; Kim, Hyo-Bin; Choi, Jeong Hee

doi:10.4168/aair.2023.15.2.145

Cited by 8 publications

(5 citation statements)

References 59 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 14 SLIT is considered for 1) patients whose symptoms are not adequately controlled by conventional pharmacotherapy, such as H1-antihistamines or topical medications, 2) patients who show side effects of pharmacotherapy, 3) patients who want to reduce or avoid long-term pharmacotherapy, 4) patients who do not want to continue SCIT because they experienced systemic side effects during administration, and 5) patients who have shown low compliance with SCIT, including resistance to injection therapy. 14 15 16 17 The efficacy of SLIT has been demonstrated in adults as well as children and adolescents. 18 19 20 21 No minimum age at which SLIT can be initiated has been defined, and age was shown not to be a major limitation, when based on data on the safety of SLIT in infants.…”

Section: Indications and Contraindicationsmentioning

confidence: 99%

The KAAACI Guidelines for Sublingual Immunotherapy

Min,

Jee,

Lee

et al. 2024

Allergy Asthma Immunol Res

Self Cite

View full text Add to dashboard Cite

Allergen immunotherapy is regarded as the only disease-modifying treatment option for various allergic conditions, including allergic rhinitis and asthma. Among the routes of administration of allergens, sublingual immunotherapy (SLIT) has gained clinical interest recently, and the prescription of SLIT is increasing among patients with allergies. After 30 years of SLIT use, numerous pieces of evidence supporting its efficacy, safety, and mechanism allows SLIT to be considered as an alternative option to subcutaneous immunotherapy. Based on the progressive development of SLIT, the current guideline from the Korean Academy of Asthma, Allergy, and Clinical Immunology aims to provide an expert opinion by allergy, pediatrics, and otorhinolaryngology specialists with an extensive literature review. This guideline addresses the use of SLIT, including 1) mechanisms of action, 2) appropriate patient selection for SLIT, 3) the currently available SLIT products in Korea, and 4) updated information on its efficacy and safety. This guideline will facilitate a better understanding of practical considerations for SLIT.

show abstract

Section: Indications and Contraindicationsmentioning

confidence: 99%

The KAAACI Guidelines for Sublingual Immunotherapy

Min,

Jee,

Lee

et al. 2024

Allergy Asthma Immunol Res

Self Cite

View full text Add to dashboard Cite

show abstract

“…Recently, the Korean Academy of Asthma, Allergy and Clinical Immunology revised clinical guidelines of AR to address key clinical questions of the management of AR [ 3 , 5 ]. Part 1 of the revised guideline covers the pharmacological management and part 2 covers nonpharmacological management of patents with AR in Korea.…”

Section: Conventional Guideline-based Managementmentioning

confidence: 99%

“…The action-plan for perennial (e.g., house dust mite, HDM), seasonal (e.g., pollen), and episodic intermittent (e.g., dog or cat) may have some similarities, but may also have some differences based on the specific triggers and symptoms that are experienced. The action-plan for HDM may focus on more measures to reduce exposure to HDM in indoor during year-round, however those for pollen may focus on avoidance measure in outdoor during a specific pollen season.Although level of evidence is not strong,allergy-proof bedding, removing carpet, use of high efficiency particulate air filter, and keeping pets out of bedroom are common plan for AR patients [ 3 ]. However, frequent ventilation, reducing humidity below 50% are recommended in a patient triggered by HDM.In pollen AR, avoidance outdoor activity, less ventilation, changing clothes and bathing after outdoor activity, and monitoring pollen counts using an application during pollen season differ from whom with HDM allergy.…”

Section: Personalized Action-plan and As-needed Therapymentioning

confidence: 99%

Action-plan and as-needed therapy in allergic rhinitis

Yang

2024

Clin Exp Pediatr

Self Cite

View full text Add to dashboard Cite

Action-plan is a written set of instructions that helps patient manage their symptoms and respond to worsening of their condition. The action-plan usually includes information on how to recognize, treat, and prevent worsening of symptoms. The plan also helps patient understand when to use their medications, how much to use, and how often to use them as-needed. An action-plan should be developed through a discussion between the patient and the physician, reflecting the patient's severity, preferences, and values and should be regularly updated to reflect changes in the person's condition. In asthma, action-plans and as-needed therapy are already well utilized. Unlike asthma, the importance of an action-plan has been overlooked in allergic rhinitis (AR), but its importance has recently been recognized. AR is a chronic condition that affects people differently, and can cause a range of symptoms, including nasal congestion, runny nose, sneezing, itching, and watery eyes. Therefore, an action-plan and as-needed therapy can help patients manage these symptoms more effectively, reducing the impact on their daily activities and quality of life. Furthermore, it can be tailored to meet the personal needs of each patient, based on the severity of their symptoms, their triggers, and their overall health. Because action-plan can help patients adhere to their treatment regimen by providing clear instructions on when and how to take medication, it can help patients stay on track with their treatment, reducing the likelihood of missed doses and treatment failures. Overall, an action-plan and as-needed therapy are important components of a comprehensive treatment plan for patients with AR. They can help to improve symptom control, prevent complications, and promote adherence to treatment, leading to better outcomes and a higher quality of life.

show abstract

“…Non-pharmacological remedies include nasal saline lavage (using isotonic or hypertonic solutions), natural products, and avoidance measures. 77 In particular, nasal lavage is particularly fruitful as it removes allergens, inflammatory mediators, and excessive secretions using isotonic solutions. 78 Hypertonic saline solutions also medicate the nasal cavity as they exert anti-inflammatory and decongestant activities.…”

Section: Integration Into Clinical Carementioning

confidence: 99%

Self-Management in Allergic Rhinitis: Strategies, Outcomes and Integration into Clinical Care

Ciprandi

2023

JAA

View full text Add to dashboard Cite

Allergic rhinitis (AR) is a common disease, characterized by typical symptoms and type 2 inflammation. Standard treatment is usually effective and safe, and most medications are available as over-the-counter (OTC). Therefore, AR patients, mostly at the AR onset or if symptoms are mild, prefer to manage symptoms themselves. However, self-management could be associated with problems, including inadequate control or medication abuse. Therefore, this paper aimed at presenting and discussing this issue. Ideally, self-management should be conducted under medical supervision. In this regard, telemedicine could represent a valuable tool for implementing self-management. Visual analog scale (VAS) is a perfect parameter to measure symptom severity, medications use, and AR control. In addition, VAS is easily monitored over time. Presently, a mobile application allows to AR patients of self-managing themselves. Therefore, mobile healthcare may supply fundamental support in communication and decision-making. In this regard, VAS represents the best tool to monitor symptoms’ severity and control over time. Finally, pharmacological and non-pharmacological remedies are numerous and effective but should be used wisely.

show abstract

KAAACI Allergic Rhinitis Guidelines: Part 2. Update in Non-pharmacological Management

Cited by 8 publications

References 59 publications

The KAAACI Guidelines for Sublingual Immunotherapy

The KAAACI Guidelines for Sublingual Immunotherapy

Action-plan and as-needed therapy in allergic rhinitis

Self-Management in Allergic Rhinitis: Strategies, Outcomes and Integration into Clinical Care

Contact Info

Product

Resources

About